NICE reports on Adherium Smartinhaler for asthma management
Filed with ASX · · 3 pages · English
In the deck
Story so far
Earlier from Adherium
- Adherium Smartinhaler dramatically improves outcomes
- Appendix 4C - quarterly for period ended 30 Sept 2016
- Key Technology Patent Granted in US
- Adherium and AstraZeneca Australia Commercial Pilot Program
- Adherium Executes Placement to Fidelity International
Later from Adherium
- Appendix 4C - quarterly December 2016
- Adherium Appoints New CEO to Drive Global Growth
- Commitments Test Entity - Fourth Quarter Report
- Investor Conference Call Presentation
- Adherium receives US FDA 510k clearance
Follow Adherium into a list and get an email when it puts out news.
Follow Adherium